Statins of high versus low cholesterol-lowering efficacy and the development of severe renal failure

A 10-Year Experience with Universal Health Insurance in Taiwan: Measuring Changes in Health and Health Disparity

(2013) Chi Pang Wen et al.   ANNALS OF INTERNAL MEDICINE

The Role of Statins in Chronic Kidney Disease

(2011) Rigas G. Kalaitzidis et al.   AMERICAN JOURNAL OF NEPHROLOGY

Longitudinal Assessment of Estimated Glomerular Filtration Rate in Apparently Healthy Adults: A Post hoc Analysis from the JUPITER Study (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)

(2011) Donald G. Vidt et al.   CLINICAL THERAPEUTICS

Role of statins in preventing adverse cardiovascular outcomes in patients with chronic kidney disease

(2011) Sankar D Navaneethan et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Potential Benefit of Statin Therapy for Dyslipidemia with Chronic Kidney Disease: Fluvastatin Renal Evaluation Trial (FRET)

(2011) Teruo Inoue et al.   INTERNAL MEDICINE

Effects of Pitavastatin (LIVALO Tablet) on the Estimated Glomerular Filtration Rate (eGFR) in Hypercholesterolemic Patients with Chronic Kidney Disease

(2011) Kenjiro Kimura et al.   Journal of Atherosclerosis and Thrombosis

No Evidence for Statin-induced Proteinuria in Healthy Volunteers as Assessed by Proteomic Analysis

(2011) Anja Verhulst et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Do HMG-CoA reductase inhibitors improve kidney function? The saga continues

(2011) Vito M. Campese et al.   JOURNAL OF NEPHROLOGY

Association between statin treatment and outcome in relation to renal function in survivors of myocardial infarction

(2011) Karolina Szummer et al.   KIDNEY INTERNATIONAL

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

(2011) Colin Baigent et al.   LANCET

Comparison of Clinical Outcomes of Hydrophilic and Lipophilic Statins in Patients with Acute Myocardial Infarction

(2011) Min Chul Kim et al.   KOREAN JOURNAL OF INTERNAL MEDICINE

New evidence on pitavastatin: efficacy and safety in clinical studies

(2010) Tamio Teramoto et al.   EXPERT OPINION ON PHARMACOTHERAPY

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors prevent the progression of renal dysfunction in Japanese hypertensive patients

(2010) Masanori Kuwabara et al.   Geriatrics & Gerontology International

Efficacy of Rosuvastatin Among Men and Women With Moderate Chronic Kidney Disease and Elevated High-Sensitivity C-Reactive Protein

(2010) Paul M. Ridker et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Epidemiology, impact and preventive care of chronic kidney disease in Taiwan

(2010) SHANG-JYH HWANG et al.   NEPHROLOGY

Public health impact of statin prescribing strategies based on JUPITER

(2010) David Nanchen et al.   PREVENTIVE MEDICINE

Pravastatin and cardiovascular risk in moderate chronic kidney disease

(2009) Haruo Nakamura et al.   ATHEROSCLEROSIS

Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis

(2009) Bengt C. Fellström et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dyslipidemia in Chronic Kidney Disease: Managing a High-Risk Combination

(2009) Veeraish Chauhan et al.   POSTGRADUATE MEDICINE

Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments

(2008) Edward J. Mills et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Pravastatin improves renal ischemia–reperfusion injury by inhibiting the mevalonate pathway

(2008) Satoru Sharyo et al.   KIDNEY INTERNATIONAL

Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials

(2008) Giovanni F M Strippoli et al.   BMJ-British Medical Journal